TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients A non-randomized retrospective study 英文论文文献.docVIP

下载本文档

5
0
约6.18万字
约 13页
2017-05-08 发布于上海
举报

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients A non-randomized retrospective study 英文论文文献.doc

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients A non-randomized retrospective study 英文论文文献

BMC Cancer BioMedCentral Research article Open Access TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study Jolanta Kupryjanczyk*1,4, Ewa Kraszewska2, Izabela Ziolkowska-Seta3, Radoslaw Madry5, Agnieszka Timorek6, Janina Markowska5, Jerzy Stelmachow6, Mariusz Bidzinski3 for the Polish Ovarian Cancer Study Group (POCSG) Address: 1Department of Molecular Pathology, the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentgena 5, 02- 781 Warsaw, Poland, 2Department of Gastroenterology and Hepat

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients A non-randomized retrospective study 英文论文文献.docVIP